A team of researchers led by bioengineers at the Georgia Institute of Technology is expanding the precision and ability of a revolutionary immunotherapy that is already transforming oncology. CAR T-Cell therapy has been hailed by patients, clinical-researchers, investors, and the media as a viable cure for some cancers.
CAR T Cell Modifications Show Improvement for Treating Solid Tumors clinicalomics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalomics.com Daily Mail and Mail on Sunday newspapers.
Georgia Tech Celebrates National Cancer Survivor Month gatech.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gatech.edu Daily Mail and Mail on Sunday newspapers.
Credits: Photo: Bryce Vickmark Caption: This image shows how lung cancer cells with a mutation of a gene (in green) invade surrounding tissues and start to spread, called metastasis. Credits: Image: Scott Wilkinson, Adam Marcus, National Cancer Institute and Winship Cancer Institute of Emory University
Previous image
Next image
In the fight against severe diseases like cancer, patients often endure a discomforting, weekslong gap between when treatment begins and when doctors can tell if it’s working. The problem often stems from an inability to track the disease’s progression in anything close to real time.
Now Glympse Bio, a startup spun out of the lab of Sangeeta Bhatia, the John J. and Dorothy Wilson Professor of Electrical Engineering